These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33270844)

  • 21. An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma.
    Singh HP; Shayler DWH; Fernandez GE; Thornton ME; Craft CM; Grubbs BH; Cobrinik D
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2200721119. PubMed ID: 35867756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles.
    Shi C; Huang K; Soto J; Sankaran R; Kalia V; Onwumere O; Young M; Einbond L; Redenti S
    Biomed Pharmacother; 2023 May; 161():114554. PubMed ID: 36940616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockdown of Long Noncoding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis by Targeting miR-124 in Retinoblastoma.
    Liu S; Yan G; Zhang J; Yu L
    Oncol Res; 2018 May; 26(4):581-591. PubMed ID: 28550678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA THOR acts as a retinoblastoma promoter through enhancing the combination of c-myc mRNA and IGF2BP1 protein.
    Shang Y
    Biomed Pharmacother; 2018 Oct; 106():1243-1249. PubMed ID: 30119193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic differences between retinoma and retinoblastoma.
    Sampieri K; Mencarelli MA; Epistolato MC; Toti P; Lazzi S; Bruttini M; De Francesco S; Longo I; Meloni I; Mari F; Acquaviva A; Hadjistilianou T; Renieri A; Ariani F
    Acta Oncol; 2008; 47(8):1483-92. PubMed ID: 18785023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [From gene to disease; retinoblastoma and the RB1 gene].
    Scheffer H; Imhof SM; Moll AC
    Ned Tijdschr Geneeskd; 2001 Jun; 145(26):1245-7. PubMed ID: 11455690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Level
    Roohollahi K; de Jong Y; van Mil SE; Fabius AWM; Moll AC; Dorsman JC
    Ophthalmol Sci; 2022 Sep; 2(3):100188. PubMed ID: 36245757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo evolved gene product NCYM in the pathogenesis and clinical outcome of human neuroblastomas and other cancers.
    Suenaga Y; Nakatani K; Nakagawara A
    Jpn J Clin Oncol; 2020 Aug; 50(8):839-846. PubMed ID: 32577751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
    Pappas L; Xu XL; Abramson DH; Jhanwar SC
    Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1.
    Bowles E; Corson TW; Bayani J; Squire JA; Wong N; Lai PB; Gallie BL
    Genes Chromosomes Cancer; 2007 Feb; 46(2):118-29. PubMed ID: 17099872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which retinoblastoma patients should be screened for RB1 mutations?
    Cowell JK; Gallie BL
    Eur J Cancer; 1998 Nov; 34(12):1825-6. PubMed ID: 10023301
    [No Abstract]   [Full Text] [Related]  

  • 32. Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence.
    Taschner-Mandl S; Schwarz M; Blaha J; Kauer M; Kromp F; Frank N; Rifatbegovic F; Weiss T; Ladenstein R; Hohenegger M; Ambros IM; Ambros PF
    Oncotarget; 2016 Jan; 7(3):3571-86. PubMed ID: 26657295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA MYCNOS facilitates proliferation and invasion in hepatocellular carcinoma by regulating miR-340.
    Yu J; Ou Z; Lei Y; Chen L; Su Q; Zhang K
    Hum Cell; 2020 Jan; 33(1):148-158. PubMed ID: 31776854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p.
    Wu XZ; Cui HP; Lv HJ; Feng L
    Biomed Pharmacother; 2019 Apr; 112():108627. PubMed ID: 30797143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-142-5p serves as a tumor suppressor in retinoblastoma cells by regulating MYCN.
    Li H; Fan D; Wang W; Zhang X; Song L; Huang Y
    Biochem Biophys Res Commun; 2021 Oct; 574():20-26. PubMed ID: 34425282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TAp63 represses transcription of MYCN/NCYM gene and its high levels of expression are associated with favorable outcome in neuroblastoma.
    Suenaga Y; Yamamoto M; Sakuma T; Sasada M; Fukai F; Ohira M; Yamaguchi Y; Yamamoto T; Ando K; Ozaki T; Nakagawara A
    Biochem Biophys Res Commun; 2019 Oct; 518(2):311-318. PubMed ID: 31427086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis of the RB1 gene in Indian patients with retinoblastoma.
    Ata-ur-Rasheed M; Vemuganti Gk; Honavar Sg; Ahmed N; Hasnain Se; Kannabiran C
    Ophthalmic Genet; 2002 Jun; 23(2):121-8. PubMed ID: 12187430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence.
    Wu N; Jia D; Bates B; Basom R; Eberhart CG; MacPherson D
    J Clin Invest; 2017 Mar; 127(3):888-898. PubMed ID: 28165337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression.
    Liu J; Ottaviani D; Sefta M; Desbrousses C; Chapeaublanc E; Aschero R; Sirab N; Lubieniecki F; Lamas G; Tonon L; Dehainault C; Hua C; Fréneaux P; Reichman S; Karboul N; Biton A; Mirabal-Ortega L; Larcher M; Brulard C; Arrufat S; Nicolas A; Elarouci N; Popova T; Némati F; Decaudin D; Gentien D; Baulande S; Mariani O; Dufour F; Guibert S; Vallot C; Rouic LL; Matet A; Desjardins L; Pascual-Pasto G; Suñol M; Catala-Mora J; Llano GC; Couturier J; Barillot E; Schaiquevich P; Gauthier-Villars M; Stoppa-Lyonnet D; Golmard L; Houdayer C; Brisse H; Bernard-Pierrot I; Letouzé E; Viari A; Saule S; Sastre-Garau X; Doz F; Carcaboso AM; Cassoux N; Pouponnot C; Goureau O; Chantada G; de Reyniès A; Aerts I; Radvanyi F
    Nat Commun; 2021 Sep; 12(1):5578. PubMed ID: 34552068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation.
    Qi DL; Cobrinik D
    Oncogene; 2017 Mar; 36(13):1760-1769. PubMed ID: 27748758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.